Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on Dec 05, 2018 7:31pm
89 Views
Post# 29072670

RE:Aphria upside not driven by Latin America

RE:Aphria upside not driven by Latin America
Zevo wrote: Good article. If aphria overpaid for LATAM assets, then everyone overpaid.  canopy paid 197 million for assets in Columbia. Aurora paid 290 million for ICC Labs.

https://grizzle.com/hindenburg-hit-piece-fyi-aphria-upside-not-driven-by-latin-america/



70M+ of Canopy's purchase went to bonuses paid to " a critical employee". This is how business is done in third world countries. You need to pay someone
Bullboard Posts